Cargando…

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models

Alzheimer’s disease (AD) is a central nervous system degenerative disease, with no effective treatment to date. Administration of immune checkpoint inhibitors significantly reduces neuronal damage and tau hyperphosphorylation in AD, but the specific mechanism is unclear. Here, we found that programm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Yulian, Gan, Chen-Ling, Xin, Zhiming, Zhang, Hai-Tao, Zhang, Qi, Lee, Tae Ho, Pan, Xiaodong, Chen, Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716757/ https://www.ncbi.nlm.nih.gov/pubmed/34977020 http://dx.doi.org/10.3389/fcell.2021.769229

Ejemplares similares

Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction
por: Zhang, Xingyu, et al.
Publicado: (2021)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons
por: Ploia, Cristina, et al.
Publicado: (2010)

Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
Publicado: (2023)

Glycogen synthase kinase 3β (GSK3β) and presenilin (PS) are key regulators of kinesin-1-mediated cargo motility within axons
por: Banerjee, Rupkatha, et al.
Publicado: (2023)

Functional Implications of Glycogen Synthase Kinase-3-Mediated Tau Phosphorylation
por: Hanger, Diane P., et al.
Publicado: (2011)

Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease
por: Dong, Yue, et al.
Publicado: (2022)

Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022)

Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
por: Zhang, Huiqin, et al.
Publicado: (2021)

Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer’s disease
por: Ivanov, Stefan M., et al.
Publicado: (2020)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013)

Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression
por: Cortés‐Gómez, María‐Ángeles, et al.
Publicado: (2020)

Calcium Ions Stimulate the Hyperphosphorylation of Tau by Activating Microsomal Prostaglandin E Synthase 1
por: Cao, Long-Long, et al.
Publicado: (2019)

Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease☆
por: Zheng, Xianhong, et al.
Publicado: (2012)

The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease
por: Liu, Zhenzhen, et al.
Publicado: (2015)

Morphometric alterations of Golgi apparatus in Alzheimer's disease are related to tau hyperphosphorylation
por: Antón-Fernández, Alejandro, et al.
Publicado: (2017)

Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation
por: Stefanoska, Kristie, et al.
Publicado: (2022)

Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration
por: Zhou, Qiuzhi, et al.
Publicado: (2022)

The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
por: Huang, Wendi, et al.
Publicado: (2023)

High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation
por: Azorsa, David O, et al.
Publicado: (2010)

Differential Hyperphosphorylation of Tau-S199, -T231 and -S396 in Organotypic Brain Slices of Alzheimer Mice. A Model to Study Early Tau Hyperphosphorylation Using Okadaic Acid
por: Foidl, Bettina M., et al.
Publicado: (2018)

Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment
por: Martinez, Ana, et al.
Publicado: (2011)

Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3
por: Mines, Marjelo A., et al.
Publicado: (2011)

Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?
por: Koistinaho, Jari, et al.
Publicado: (2011)

MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer’s disease
por: Wang, Gang, et al.
Publicado: (2016)

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
por: Guo, Yanjun, et al.
Publicado: (2016)

The Link Between Diabetes Mellitus and Tau Hyperphosphorylation: Implications for Risk of Alzheimer's Disease
por: Hobday, Amy L, et al.
Publicado: (2021)

Diacylglycerol Kinases in T Cell Tolerance and Effector Function
por: Chen, Shelley S., et al.
Publicado: (2016)

Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors
por: Bretteville, Alexis, et al.
Publicado: (2012)

Identification of potent inhibitors of microtubule affinity regulating kinase for inhibition of tau hyperphosphorylation
por: Levy, Alison, et al.
Publicado: (2013)

The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer's disease
por: Jayapalan, Saranya, et al.
Publicado: (2013)

Glycogen Synthase Kinase-3 Regulates Production of Amyloid-β Peptides and Tau Phosphorylation in Diabetic Rat Brain
por: Qu, Zhong-Sen, et al.
Publicado: (2014)

Immunological memory to hyperphosphorylated tau in asymptomatic individuals
por: Pascual, Gabriel, et al.
Publicado: (2017)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

Inhibition of glycogen synthase kinase-3 by BTA-EG(4) reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer’s disease
por: Croft, Cara L., et al.
Publicado: (2017)

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease
por: Nitschke, Felix, et al.
Publicado: (2017)

Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer’s Disease-Related Epileptic Seizures
por: Lin, Runxuan, et al.
Publicado: (2020)

Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau
por: Melov, Simon, et al.
Publicado: (2007)

Hyperphosphorylated tau in young and middle-aged subjects
por: Elobeid, Adila, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pfo5b28m5fobded0ddjmsq4850